FDA Expands Use of Breast Cancer Drug Kisqali
WEDNESDAY, Sept. 18, 2024 (HealthDay News) — Women with early stage breast cancer may now take Kisquali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration’s expanded approval of the treatment, drug maker Novartis announced Tuesday. “The FDA approval of Kisqali for this early breastContinue Reading